+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

Beauty and Personal Care in Kenya - Product Thumbnail Image

Beauty and Personal Care in Kenya

  • Report
  • August 2025
  • 106 Pages
  • Kenya
From
From
Women's Health Devices Market Report 2026 - Product Thumbnail Image

Women's Health Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Integrase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Integrase Inhibitors - Global Strategic Business Report

  • Report
  • November 2026
  • 371 Pages
  • Global
From
Cartilage Repair Market 2024-2028 - Product Thumbnail Image

Cartilage Repair Market 2024-2028

  • Report
  • March 2024
  • 162 Pages
  • Global
From
Tourette Syndrome Treatment Market - Product Thumbnail Image

Tourette Syndrome Treatment Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Alzheimer's Disease Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 189 Pages
  • Global
From
From
Anxiolytics - Global Strategic Business Report 2026 - Product Thumbnail Image

Anxiolytics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 108 Pages
  • Global
From
From
From
From
From
H 4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

H 4 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
H 3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

H 3 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator